Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 3: Follow-up of “negative for malignancy” biopsies
Patients’ Characteristics and Lesion Management No. %
Initially “negative for malignancy” biopsies 43/184 23%
Patients with a known malignancy 29/43 68%
 Rebiopsied/excised 7/29 20%
 Ultimately +malignancy 4/7 57%
 Stable/resolved (mean f/u time: 32 mo, 2–120 mo) 17/29 59%
 No f/u 5/29 17%
Patients without known malignancy 14/43 32%
 Rebiopsied/excised 5/14 36%
 Ultimately + malignancy 0/5 0%
 Stable/resolved (mean f/u time: 25.6 mo, 1–72 mo) 7/14 50%
 No f/u 2/14 14%
Total false-negative rate 4/184 2%
Total diagnostic yield 167/184 91%
Note:—f/u indicates follow-up.

Patients’ Characteristics and Lesion Management	No.	%
Initially “negative for malignancy” biopsies	43/184	23%
Patients with a known malignancy	29/43	68%
Rebiopsied/excised	7/29	20%
Ultimately +malignancy	4/7	57%
Stable/resolved (mean f/u time: 32 mo, 2–120 mo)	17/29	59%
No f/u	5/29	17%
Patients without known malignancy	14/43	32%
Rebiopsied/excised	5/14	36%
Ultimately + malignancy	0/5	0%
Stable/resolved (mean f/u time: 25.6 mo, 1–72 mo)	7/14	50%
No f/u	2/14	14%
Total false-negative rate	4/184	2%
Total diagnostic yield	167/184	91%